Pseudo-stroke manifestation of multiple myeloma: a report of two cases with literature review. 2013

Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
Department of Pathology, Medical University of Gdansk, Gdansk, Poland. czapiewskipiotr@gumed.edu.pl

Multiple myeloma rarely presents with neurological symptoms. We describe two patients with pseudo-stroke manifestation of multiple myeloma. The first patient was a 60-year-old female with the initial presentation of multiple myeloma forming a large skull tumour compressing the brain with resultant symptoms of aphasia, limited logical contact and right upper extremity paresis. The second patient was a 69-year-old female who presented with a partial motor epileptic seizure involving both right limbs with persisting weakness of muscles and speech disturbances due to a skull tumour 4 years after the diagnosis of multiple myeloma. Pseudo-stroke manifestation of multiple myeloma is extremely uncommon, however it can sometimes be observed both as an initial presentation and in the course of long-lasting disease.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013064 Speech Disorders Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language. Aprosodia,Aprosodic Speech,Cluttering,Dysglossia,Dyslalia,Rhinolalia,Verbal Fluency Disorders,Aprosodias,Clutterings,Dysglossias,Dyslalias,Rhinolalias,Speech, Aprosodic,Verbal Fluency Disorder
D018908 Muscle Weakness A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251) Muscular Weakness,Muscle Weaknesses,Muscular Weaknesses,Weakness, Muscle,Weakness, Muscular,Weaknesses, Muscle,Weaknesses, Muscular

Related Publications

Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
August 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
October 2023, Annales de cardiologie et d'angeiologie,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
June 2017, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
July 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
October 2018, BMC infectious diseases,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
February 1946, Proceedings of the staff meetings. Mayo Clinic,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
July 1992, New York state journal of medicine,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
October 1985, Boletin de la Asociacion Medica de Puerto Rico,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
January 1986, Hematological oncology,
Piotr Czapiewski, and Tomasz Szmuda, and Jarosław Dzierżanowski, and Paweł Słoniewski, and Krzysztof Sworczak, and Maria Gnacińska, and Mirosława Dubaniewicz-Wybieralska, and Andrzej Hellmann, and Wojciech Biernat
September 2020, Medicine,
Copied contents to your clipboard!